All studies
Not yet recruitingOBSERVATIONAL

Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance

This study gathers information from patients in the Netherlands and France who are having special, less invasive treatments for cancers in the liver, kidney, lung, or bone. These treatments are standard care and include procedures that destroy tumors or deliver medicine directly to them using tiny tubes. During these treatments, an advanced CT scanner called a spectral angio-CT is used. This scanner takes extra detailed pictures beyond what doctors normally see. The study aims to understand if these extra pictures can help doctors plan treatments better, guide procedures more accurately, and predict treatment success in the future. Patients' treatments and follow-up are not changed by being part of this study.

At a glance

What is this study about?

This study is gathering information about a new way doctors are using imaging during cancer treatments. For certain cancers in organs like the liver, kidney, lung, and bones, doctors can offer 'minimally invasive' treatments. This means they use small tools and techniques, often guided by scans, rather than major surgery. Examples include procedures that destroy cancer cells with heat or cold, or those that deliver medications directly to the tumour through small tubes.

During these procedures, standard imaging is always used to help doctors see what they are doing. This study uses a very advanced type of CT scanner called a 'spectral angio-CT'. This machine takes even more detailed pictures than regular scans. It gives doctors extra information that isn't usually looked at right now. The main goal of this study is to see if this additional, detailed imaging information can help improve how these treatments are planned, guided, and how successful they are in the longer term. Essentially, they want to find out if these super-detailed scans can lead to even better outcomes for patients in the future.

It's important to know that if you take part, your treatment itself won't change. You will receive the standard care your doctors recommend for your condition. The study is simply collecting information from your medical records and scans to learn how this advanced imaging works. Your involvement won't affect your treatment plan, the care you receive, or your follow-up appointments.

Key takeaways

  • The study gathers information about advanced imaging used during certain cancer treatments.
  • It focuses on minimally invasive treatments for cancers in the liver, lung, kidney, and bone.
  • Participation does not change your treatment or follow-up care.
  • The goal is to see if new scanning technology can improve future cancer care.
  • Only patients receiving care with a specific advanced CT scanner are eligible.

Who may be eligible?

To be able to take part in this study, you would generally need to be at least 18 years old. You must also be scheduled to have a specific type of cancer treatment that is considered 'minimally invasive'. This means procedures done with small tubes or needles, rather than big surgery, for solid tumours in areas like your liver, kidney, lung, or bones.

Crucially, the hospital where you're having your treatment must be using the special 'spectral angio-CT' scanner as part of your standard care. Finally, you would need to understand and agree in writing to participate in the study.

There are a few reasons why someone might not be able to join. If a person is legally unable to make their own decisions, or if they have mental health conditions that prevent them from fully understanding what it means to take part, then they wouldn't be eligible for this study.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. Are you 18 years old or older?
  2. Are you having a minimally invasive procedure for cancer in your liver, kidney, lung, or bone?
  3. Is your hospital using a special 'spectral angio-CT' scanner for your procedure?
  4. Can you understand and give written permission to take part in the study?
Answer every question to see your result.

What does participation involve?

If you choose to take part in this study, you won't need to do anything extra. This is because the study simply collects information from your existing medical records and the scans you already have as part of your standard treatment. You won't have any additional visits, assessments, or medications related to the study itself. Your cancer treatment and all your follow-up appointments will continue exactly as your medical team recommends. The study does not change any part of your clinical care or how long your treatment or follow-up lasts.

Potential risks and benefits

Since this study only involves collecting information from your routine medical care and scans, there are generally no direct risks to you from participating. Your treatment will not be changed, and no experimental procedures are involved. While there are no direct personal benefits to you from taking part, the information gathered could help improve cancer treatments for future patients. You have the right to withdraw your consent to have your data included at any time without affecting your medical care.

Locations (3)

  • Hospices Civils de Lyon - Hôpital Édouard Herriot
    Verified postcode
    Lyon, France
  • Assistance Publique Hopitaux de Paris - Hôpital Henri Mondor
    Verified postcode
    Créteil, France
  • Leiden University Medical Center
    Verified postcode
    Leiden, Netherlands

Common questions

What kind of treatments does this study look at?

It looks at less invasive treatments for cancers in the liver, kidney, lung, and bone, like procedures that destroy tumours or deliver medicines directly to them.

Will my treatment change if I join this study?

No, your treatment and follow-up will not change at all. You will receive the standard care your doctors recommend.

What is 'spectral angio-CT'?

It's an advanced type of CT scanner that takes extra-detailed pictures during your treatment that aren't usually seen with regular scans.

Why is this study being done?

The study wants to see if the extra details from these advanced scans can help doctors plan treatments better and predict results more accurately in the future.

Are there any extra tests for me?

No, there are no extra tests, visits, or procedures. The study just collects information from your existing medical records and scans.

How to find out more

Emma C.M. Buijsman, MSc

Always speak to your GP or specialist before deciding to take part in a study.

Interested in taking part?

Register your interest

Share your details and the research team for "Registry of Minimally Invasive Cancer Treatment Using Spectr…" will contact you if you may be eligible. Always speak to your GP before agreeing to take part.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.